Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

about

Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

Item

http://www.wikidata.org/entity/Q49334257

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

@en

Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

@nl

type

Item

label

Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

@en

Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

@nl

prefLabel

Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

@en

Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

@nl

P1476

Anti-hyperglycemic effects and signaling mechanism of Perilla frutescens sprout extract.

@en

P2093

Da-Hye Kim

http://www.w3.org/2001/XMLSchema#string

Kang-Yeol Yu

http://www.w3.org/2001/XMLSchema#string

Sang Jun Kim

http://www.w3.org/2001/XMLSchema#string

Seon-Young Kim

http://www.w3.org/2001/XMLSchema#string

Seung-Il Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

Metformin and metabolic diseases: a focus on hepatic aspects

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism

Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase.

Oral antihyperglycemic therapy for type 2 diabetes: scientific review.

Glucose toxicity.

Hypoglycemic effects of aqueous persimmon leaf extract in a murine model of diabetes

Consequences of AphanizomenonFlos-aquae(AFA) extract (Stemtech (TM) ) on metabolic profile of patients with type 2 diabetes

α-Glucosidase inhibitors and their use in clinical practice

A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications.

P304

20-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4162/NRP.2018.12.1.20

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29399293

http://www.w3.org/2001/XMLSchema#string

P921

hyperglycemia

P932

5792252

http://www.w3.org/2001/XMLSchema#string